Patents by Inventor Kevin John JOSE

Kevin John JOSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190161543
    Abstract: Alterations in bioreactor cell culture feeding to an extended or continuous feed following an initial period of no feeding reduces the level of high molecular weight, acid charge, and fragment species of monoclonal antibodies expressed in the culture, and enhances the level of afucosylated species of monoclonal antibodies expressed in the culture. Regular fucose infusions following an initial period of no feed media infusion reduces the level of afucosylated species of monoclonal antibodies expressed in the culture. Cell culture manipulation may be used to modulate the level of species of monoclonal antibodies.
    Type: Application
    Filed: January 5, 2017
    Publication date: May 30, 2019
    Inventors: Marc SANTORO, Kevin John JOSE, Sri MADABHUSHI, Scott GANGLOFF
  • Publication number: 20190048070
    Abstract: Alterations in bioreactor cell culture feeding to an extended or continuous feed following an initial period of no feeding reduces the level of high molecular weight, acid charge, and fragment species of monoclonal antibodies expressed in the culture, and enhances the level of afucosylated species of monoclonal antibodies expressed in the culture. Regular fucose infusions following an initial period of no feed media infusion reduces the level of afucosylated species of monoclonal antibodies expressed in the culture. Cell culture manipulation may be used to modulate the level of species of monoclonal antibodies.
    Type: Application
    Filed: January 5, 2017
    Publication date: February 14, 2019
    Inventors: Marc SANTORO, Kevin John JOSE, Sri MADABHUSHI, Scott GANGLOFF